Donnell R F
Division of Urology, Department of Surgery, The Medical College of Wisconsin 53226, USA.
Surg Oncol Clin N Am. 1999 Oct;8(4):693-702, vii.
Prostate cancer is the second leading cause of cancer related death in men over the age of 50 in the United States today. The serum prostate specific antigen has the highest predictive value of any diagnostic test for prostate cancer. Highly screened communities have realized an impressive downward stage migration, younger average age at detection, and an improved five-year survival rate. These improvements are necessary components for any successful screening program.
前列腺癌是当今美国50岁以上男性中癌症相关死亡的第二大主要原因。血清前列腺特异性抗原在前列腺癌的任何诊断测试中具有最高的预测价值。筛查率高的社区已经实现了令人瞩目的分期下移、检测时的平均年龄降低以及五年生存率提高。这些改善是任何成功筛查计划的必要组成部分。
